# Nasus Pharma Ltd — Form D

Nasus Pharma Ltd of TEL AVIV, L3, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-25. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-02-25
- Form: D
- Accession: 0001493152-26-008057
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 15
- Date of first sale: 2026-02-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-574660

## Issuer

- Name: Nasus Pharma Ltd
- CIK: 0002029039
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 34 YITZHAK SADEH ST, TEL AVIV, L3, 6274711
- Phone: +972.3.573.6632

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Udi Gilboa | Director | TEL AVIV, L3 |
| Ronnie Hershman | Director | TEL AVIV, L3 |
| Isaac Israel | Director | TEL AVIV, L3 |
| Dalia Megiddo | Director | TEL AVIV, L3 |
| Sharon Shacham | Director | TEL AVIV, L3 |
| David Silberman | Director | New York, NY |
| DAN TELEMAN | Director | NESS ZIONA, L3 |
| Dalia Megiddo | Executive Officer | TEL AVIV, L3 |
| Eyal Rubin | Executive Officer | TEL AVIV, L3 |
| DAN TELEMAN | Executive Officer | NESS ZIONA, L3 |

## More

- [CIK 2029039 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2029039&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001493152-26-008057.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.